Hinge Health, Inc. (HNGE)
97.67
-0.27
(-0.28%)
USD |
NYSE |
Oct 02, 16:00
97.63
-0.04
(-0.04%)
Pre-Market: 20:00
Hinge Health Price : 97.67 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 98.30 | 99.73 | 96.95 | 97.67 | 975349.0 |
| Oct 01, 2026 | 97.00 | 98.46 | 96.32 | 97.94 | 1.416M |
| Sep 30, 2026 | 95.52 | 98.41 | 94.50 | 97.24 | 1.635M |
| Sep 29, 2026 | 94.20 | 97.95 | 91.52 | 95.21 | 1.725M |
| Sep 28, 2026 | 93.98 | 94.16 | 91.76 | 92.45 | 1.277M |
| Sep 25, 2026 | 91.94 | 96.45 | 91.03 | 95.57 | 1.091M |
| Sep 24, 2026 | 91.52 | 93.60 | 90.34 | 91.98 | 2.305M |
| Sep 23, 2026 | 93.63 | 94.28 | 89.75 | 92.28 | 1.703M |
| Sep 22, 2026 | 94.45 | 94.60 | 91.78 | 94.15 | 1.328M |
| Sep 21, 2026 | 95.08 | 95.82 | 92.92 | 94.45 | 1.126M |
| Sep 18, 2026 | 95.39 | 96.26 | 92.60 | 94.90 | 4.866M |
| Sep 17, 2026 | 93.69 | 96.66 | 93.66 | 94.72 | 2.061M |
| Sep 16, 2026 | 92.08 | 95.62 | 91.62 | 93.73 | 1.797M |
| Sep 15, 2026 | 94.73 | 95.50 | 92.36 | 92.39 | 1.164M |
| Sep 14, 2026 | 88.69 | 94.86 | 88.53 | 94.79 | 2.460M |
| Sep 11, 2026 | 89.50 | 90.81 | 86.29 | 88.59 | 1.727M |
| Sep 10, 2026 | 89.00 | 91.76 | 86.78 | 88.26 | 2.424M |
| Sep 09, 2026 | 93.76 | 93.76 | 89.07 | 91.31 | 1.514M |
| Sep 08, 2026 | 91.88 | 93.50 | 90.08 | 92.69 | 2.198M |
| Sep 04, 2026 | 90.00 | 93.14 | 89.41 | 92.37 | 1.180M |
| Sep 03, 2026 | 92.61 | 92.99 | 88.82 | 90.76 | 1.301M |
| Sep 02, 2026 | 90.55 | 93.30 | 89.96 | 91.85 | 2.541M |
| Sep 01, 2026 | 91.39 | 92.24 | 89.27 | 90.02 | 1.730M |
| Aug 31, 2026 | 86.88 | 92.69 | 85.75 | 92.56 | 2.003M |
| Aug 28, 2026 | 92.00 | 92.60 | 87.06 | 87.35 | 2.997M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| West Pharmaceutical Services, Inc. | 364.98 |
| Interpace Biosciences, Inc. | 6.025 |
| PD-Rx Pharmaceuticals, Inc. | 3.10 |
| Medical Marijuana, Inc. | 0.0001 |
| Acro Biomedical Co. Ltd. | 0.026 |
Price Related Metrics
| PE Ratio | 75.21 |
| PS Ratio | 10.98 |
| Price to Book Value | 22.75 |
| Price to Free Cash Flow | 27.84 |
| Earnings Yield | 1.33% |
| Market Cap | 7.833B |
| Operating PE Ratio | 81.33 |
| Normalized PE Ratio | 73.47 |